Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cerebrovasc Dis ; 16(1): 83-7, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12766367

RESUMO

BACKGROUND: Paradoxical embolism via persistent foramen ovale (PFO) is suspected to be a frequent cause of stroke in younger patients. We investigated whether the prevalence of the risk factors for venous thrombosis factor V Leiden (FVL) and prothrombin G20210A mutation (PT G20210A) is increased in this group of patients. METHODS: We examined FVL and PT G20210A mutation in 220 patients (group 1) with cerebral ischemia associated with a PFO and without other etiology, in 196 patients with cerebral ischemia of an etiology other than PFO (group 2), and in 362 healthy subjects (group 3) from the same region in Germany. RESULTS: Heterozygosity for the PT G20210A mutation was more common in group 1 (5.0%) than in group 3 (1.4%; sex- and age-adjusted odds ratio 3.66; 95% CI 1.25-10.75; p = 0.01). By contrast, the mutation was not more common in group 2 (2.6%; odds ratio 1.50; 95% CI 0.42-5.41; p = 0.5). Prevalences of FVL were not different between groups. CONCLUSIONS: We identified PT G20210A but not FVL - the strongest genetic risk factor for deep venous thrombosis - to be significantly associated with stroke attributed to PFO. These findings rise doubts about the concept of paradoxical brain embolism as the dominating mechanism in stroke associated with PFO.


Assuntos
Isquemia Encefálica/genética , Fator V/genética , Comunicação Interatrial/genética , Mutação/genética , Protrombina/genética , Adulto , Idoso , Isquemia Encefálica/fisiopatologia , Diabetes Mellitus/fisiopatologia , Feminino , Comunicação Interatrial/fisiopatologia , Heterozigoto , Humanos , Hipertensão/complicações , Hipertensão/fisiopatologia , Trombose Intracraniana/genética , Trombose Intracraniana/fisiopatologia , Ataque Isquêmico Transitório/genética , Ataque Isquêmico Transitório/fisiopatologia , Masculino , Pessoa de Meia-Idade , Razão de Chances , Fatores de Risco , Fumar/fisiopatologia , Acidente Vascular Cerebral/genética , Acidente Vascular Cerebral/fisiopatologia , Ultrassonografia Doppler Transcraniana
2.
Eur J Pharmacol ; 174(2-3): 237-51, 1989 Dec 19.
Artigo em Inglês | MEDLINE | ID: mdl-2630301

RESUMO

(-)-N6-(R-phenylisopropyl)-adenosine (R-PIA) depressed tritium overflow and vasoconstriction evoked by electrical stimulation to a similar extent in isolated tail arteries of Wistar rats (WR) preincubated with [3H]noradrenaline. The inhibitory effects of adenosine, 5'-N-ethylcarboxamidoadenosine (NECA) and R-PIA were determined on the constrictor responses of tail arteries obtained from WR, as well as spontaneously hypertensive (SHR) and Wistar Kyoto rats (WKY). In WR and WKY, the rank order of agonist potency (R-PIA greater than NECA greater than adenosine) was compatible with the presence of adenosine A1-receptors. Whereas adenosine, NECA and R-PIA were equiactive in WR and WKY, they produced no or only slight changes in SHR. The left renal arteries of some WR were partially occluded to induce hypertension. R-PIA had the same effect in the tail arteries of these animals as in preparations obtained from sham-operated WR. The above results suggest that the subsensitivity of presynaptic A1-receptors in the blood vessels of SHR is genetically determined. This could contribute in vivo to enhanced transmitter release from terminals of perivascular nerves and subsequent increases in vascular resistance.


Assuntos
Hipertensão/fisiopatologia , Músculo Liso Vascular/metabolismo , Receptores Purinérgicos/efeitos dos fármacos , Vasoconstrição/efeitos dos fármacos , Adenosina/análogos & derivados , Adenosina/farmacologia , Trifosfato de Adenosina/farmacologia , Adenosina-5'-(N-etilcarboxamida) , Animais , Pressão Sanguínea/efeitos dos fármacos , Estimulação Elétrica , Técnicas In Vitro , Músculo Liso Vascular/fisiologia , Norepinefrina/metabolismo , Fenilisopropiladenosina/antagonistas & inibidores , Fenilisopropiladenosina/farmacologia , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos , Ratos Endogâmicos WKY , Receptores Purinérgicos/fisiologia , Especificidade da Espécie , Teofilina/análogos & derivados , Teofilina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA